All Posts By

Smartkarma Daily Briefs

Most Read: ZOZO Inc, Fast Retailing, Shenzhen New Industries Biomedical Engineering-A, Kokusai Electric , HD Hyundai Marine Solution , Lawson Inc, Alteogen Inc, CIMC Vehicle Group Co Ltd and more

By | Daily Briefs, Most Read

In today’s briefing:

  • The Bigly March 2024 “Wednesday-Friday Trade” (Surprising Flows)
  • Fast Retailing (9983) – Now At Double Downweight Levels
  • CSI300 Index Rebalance Preview: Potential Adds Outperforming Despite ETF Inflows
  • TOPIX “Big April Basket” 2024 Expectations: More High-Conviction Names; Better Trade Ideas
  • HD Hyundai Marine Solution IPO Preview
  • KDDI Launches Tender To Buy Out Lawson (2651) – Still Far Too Cheap
  • Alteogen: Block Deal Sale of About 3% of Shares
  • Lawson (2651 JP): KDDI Corp (9433 JP) Tender Offer Launches
  • Fast Retailing: Earnings Preview
  • CIMC (1839 HK): 18th April Shareholder Vote


The Bigly March 2024 “Wednesday-Friday Trade” (Surprising Flows)

By Travis Lundy

  • Every year it’s the same trade. This year it is Wednesday and Thursday. There are risks to the analysis – notably allocation.
  • But there may be ¥1.0-1.2trln+ to buy on one day into the close later this month, then ad hoc buys of ¥630bn and index sells of ~¥600bn  2 days later.
  • Over the past ten years, the two day return on the March trade is great. This year the Nikkei funding trade makes things more complicated. 

Fast Retailing (9983) – Now At Double Downweight Levels

By Travis Lundy

  • Fast Retailing (9983 JP) is the largest weight in the Nikkei 225. On Friday, it closed at 11.36% of the Nikkei 225, putting it well above the 10% cap level.
  • If the stock is above 10% on a pro-forma basis on the base date of 31 July 2024, it will get a capping coefficient. 8.4mm shares (US$2.5bn) to sell.
  • At Friday’s close, we were borderline above a double-downweight trigger. At Monday’s open, just below. 30mins later? Back well above. Lots of interesting issues and nuances here for a short.

CSI300 Index Rebalance Preview: Potential Adds Outperforming Despite ETF Inflows

By Brian Freitas

  • With 85% of the review period complete, we see 11 changes for the Shanghai Shenzhen CSI 300 Index (SHSZ300 INDEX) in June.
  • We estimate one-way turnover of 1.2% at the rebalance leading to a one-way trade of CNY 7.3bn (US$1bn). There are a lot of stocks with multiple days ADV to trade.
  • The potential adds have outperformed the potential deletes despite large flows from the National Team into ETFs tracking the CSI 300 Index. That support for the potential deletes will reverse.

TOPIX “Big April Basket” 2024 Expectations: More High-Conviction Names; Better Trade Ideas

By Janaghan Jeyakumar, CFA

  • The Tokyo Stock Exchange (TSE) calculates Free-Float Weight (FFW) for each listed company and uses this value as a key component of TOPIX Index Calculation.
  • For companies with “low liquidity” the FFW will be multiplied by a fixed liquidity factor of 0.75 to derive the final FFW used for index calculation.
  • Every April, the application of this liquidity factor is reviewed by the TSE. In this insight, we take an early look at what could happen in April 2024.

HD Hyundai Marine Solution IPO Preview

By Douglas Kim

  • HD Hyundai Marine Solution is getting ready to complete its IPO in KOSPI in May 2024. This will be one of the largest IPOs in Korea in 2024. 
  • The IPO price range is from 73,300 won to 83,400 won. The IPO offering amount is from 652.4 billion won to 742.3 billion won. 
  • A key beneficiary of HD Hyundai Marine Solution IPO is HD Hyundai (62% ownership). Our NAV analysis suggests implied price of 95,632 for HD Hyundai (40% higher than current price).

KDDI Launches Tender To Buy Out Lawson (2651) – Still Far Too Cheap

By Travis Lundy

  • KDDI has announced the launch tomorrow of its Tender Offer to buy out the minorities in Lawson Inc (2651 JP)
  • It’s still too cheap. It is still a somewhat non-transparent and unfair process as far as I can tell. And it does not adhere to the METI Fair M&A Guidelines. 
  • There SHOULD BE some activist interest to get KDDI to bump but it is not clear that will show up. 

Alteogen: Block Deal Sale of About 3% of Shares

By Douglas Kim

  • On 27 March, Alteogen announced that Jeong Hye-shin, former Alteogen Chief Strategy Officer (CSO), sold 1.6 million shares of Alteogen stock in after-hours trading in block deal sale. 
  • The block deal sale price was 197,770 won. Alteogen’s share price declined by 10.9% today to 195,600 won. Block deal sale amount was about 316 billion won. 
  • This block deal sale combined with the sharp recent, share price increase are likely to result in a near-term consolidation of its share price in the next several months.

Lawson (2651 JP): KDDI Corp (9433 JP) Tender Offer Launches

By Arun George

  • Lawson Inc (2651 JP) has announced that the pre-condition for the KDDI Corp (9433 JP) tender offer is satisfied. The offer terms are unchanged at JPY10,360 per share. 
  • The offer is arguably light due to the market re-rating, does not reflect significant synergies and is below the midpoint of the IFA DCF valuation range. 
  • Nevertheless, the offer will likely succeed as it represents an all-time high, with no vocal opposition, an achievable 30.2% minority acceptance rate, and the shares never trading through terms. 

Fast Retailing: Earnings Preview

By Oshadhi Kumarasiri

  • While domestic revenues may have slowed, Uniqlo’s domestic OP shows upside potential driven by upside to GM and a gradual reduction in SG&A expenditure.
  • Simultaneously, Uniqlo International is exhibiting strong performance, with anticipated revenue and OP growth of 21% and 30% YoY respectively.
  • Despite expecting a strong earnings beat, concerns over high valuations and index issues make us cautious about trading Fast Retailing (9983 JP) in the current earnings cycle.

CIMC (1839 HK): 18th April Shareholder Vote

By David Blennerhassett

  • On the 11th March, SOE-backed CIMC Vehicle Group Co Ltd (1839 HK) announced a firm Offer at HK$7.50/H-share from its major shareholder, CIMC Group. Terms are final. 
  • CIMC Group holds 74.24% of the H-shares and will abstain from voting at the H-share class meeting. 14.21% of the remaining 25.76% H-shares have given irrevocables supporting the Offer.
  • The Circular is now out. The shareholder vote is the 18th April. Payment is the 13th May, IF unconditional on the first close. This looks done.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Analytics and News
  • ✓ Events & Webinars



Daily Brief Industrials: CIMC Vehicle Group Co Ltd, Sinotrans, Ocean Wilsons Holdings, CIMC Enric Holdings, US Treasury (10 Yr Generic), Isoteam Ltd, AZEK /, Simpson Manufacturing Co, Inc and more

By | Daily Briefs, Industrials

In today’s briefing:

  • CIMC Vehicles (1839 HK): Vote on 18 April as Uncertainty Lingers on the 90% Acceptance Threshold
  • Sinotrans (598. HK) Continues to Deliver
  • Quiddity Leaderboard F100/​​​250 Jun 24: LONG OCN – SHORT FSJ Could Be Interesting
  • CIMC Enric (3899 HK): Positive Takeaways from Post-Result Call
  • CIMC (1839 HK): 18th April Shareholder Vote
  • Downgrading Real Estate to Underweight; Bullish Outlook Intact; Broadening Participation
  • kopi-C with ISOTeam’s CEO: “Why I’m investing in both drones and professional development”
  • The AZEK Company: Initiation of Coverage – Is The Robust Demand in Residential Markets Likely To Last? – Major Drivers
  • Simpson Manufacturing Co.: Initiation Of Coverage – 4 Pivotal Factors Shaping Its Growth Trajectory! – Financial Forecasts


CIMC Vehicles (1839 HK): Vote on 18 April as Uncertainty Lingers on the 90% Acceptance Threshold

By Arun George

  • CIMC Vehicle Group Co Ltd (1839 HK) has despatched the offer document, and the H Share HK$7.50 offer is open. The H Shareholders class vote is on 18 April.  
  • The key condition is approval by at least 75% of independent H Shareholders (<10% of all independent H Shareholders rejection) along with a 90% minimum acceptance condition.  
  • The de-rating of peers and ongoing US investigation favours meeting the 90% threshold. However, the dire minority AGM/EGM participation rates suggest that retail apathy may derail the offer. 

Sinotrans (598. HK) Continues to Deliver

By Rikki Malik

  • Cost and business optimisations lead to increased profits as revenues drop due to freight rate declines
  • Successfully pivoting by geography as the global trading environment changes
  • The company increases its dividend payout in a sign of confidence for the future

Quiddity Leaderboard F100/​​​250 Jun 24: LONG OCN – SHORT FSJ Could Be Interesting

By Janaghan Jeyakumar, CFA

  • In this insight, we take a look at the potential index changes for F100 and F250 in the run-up to the June 2024 index rebal event.
  • There could be up to three intra-review changes for the F250 index during the next two months.
  • Separately, there could be one change for F100 and two changes for F250 during the regular rebalance in June 2024.

CIMC Enric (3899 HK): Positive Takeaways from Post-Result Call

By Osbert Tang, CFA

  • Despite weaker 2H23 results, CIMC Enric Holdings (3899 HK) guided for solid recovery in FY24. Order backlogs reached Rmb22.9bn, which almost equals the full-year revenue.
  • Clean energy segment will be supported by vessel demand, hydrogen orders, and Angang Steel project contribution. Chemical and environmental segment should rebound in 2H24.
  • Liquid food spin-off is in process and it has won several domestic whiskey projects. As net cash equals 13% of share price, payout will be maintained at 50% (FY22: 40%). 

CIMC (1839 HK): 18th April Shareholder Vote

By David Blennerhassett

  • On the 11th March, SOE-backed CIMC Vehicle Group Co Ltd (1839 HK) announced a firm Offer at HK$7.50/H-share from its major shareholder, CIMC Group. Terms are final. 
  • CIMC Group holds 74.24% of the H-shares and will abstain from voting at the H-share class meeting. 14.21% of the remaining 25.76% H-shares have given irrevocables supporting the Offer.
  • The Circular is now out. The shareholder vote is the 18th April. Payment is the 13th May, IF unconditional on the first close. This looks done.

Downgrading Real Estate to Underweight; Bullish Outlook Intact; Broadening Participation

By Joe Jasper

  • Our bullish outlook initiated on November 7, 2023 remains intact; this intermediate-to-long-term outlook is likely to stay in place as long as 4800 support holds on the SPX (7-10% downside).
  • To be clear, we aren’t calling for a pullback to 4800; we view it as a worst-case scenario for the S&P 500, and we want to be prepared for anything.
  • Shorter-Term, we remain bullish on the S&P 500 and Nasdaq 100 (QQQ) as they both refuse to close below their 20-day MAs for more than 2-3 consecutive days.

kopi-C with ISOTeam’s CEO: “Why I’m investing in both drones and professional development”

By Geoff Howie

  • kopi-C with ISOTeam’s CEO: “I’m investing in both drones and professional development” For people who live in Housing Development Board (HDB) flats in Singapore, drones may soon become a common sight.
  • ISOTeam, which specialises in maintaining and upgrading buildings, has been using drones for façade inspections since 2021.

The AZEK Company: Initiation of Coverage – Is The Robust Demand in Residential Markets Likely To Last? – Major Drivers

By Baptista Research

  • This is our first report on the AZEK Company, leading manufacturer of eco-friendly building products.
  • The company reported an 11% net sales increase year-over-year in Q1 2024.
  • Excluding the recently divested Vycom business, net sales increased 22% year-over-year, driven by the strong performance of its residential sector.

Simpson Manufacturing Co.: Initiation Of Coverage – 4 Pivotal Factors Shaping Its Growth Trajectory! – Financial Forecasts

By Baptista Research

  • This is our first report on building construction product manufacturer, Simpson Manufacturing Company.
  • The company showcased strong execution in 2023 amid a challenging year, outperforming the housing market via robust customer demand and expansion of production lines.
  • With annual net sales of $2.2 billion, a 21.5% operating income margin, and a record $8.26 of earnings per diluted share, the company emerged resilient.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Energy/Materials: Valeura Energy Inc, Boise Cascade Co, VAALCO Energy and more

By | Daily Briefs, Energy & Materials Sector

In today’s briefing:

  • Valeura Energy (TSX: VLE): Additional exploration upside. Lower decommissioning liabilities
  • Boise Cascade Corporation: These 4 Pivotal Factors Are Needle-Movers For Its Stock In 2024 & Beyond!
  • VAALCO Energy (NYSE: EGY): EG unlocked


Valeura Energy (TSX: VLE): Additional exploration upside. Lower decommissioning liabilities

By Auctus Advisors

  • FY23 production, YE23 net cash and YE23 reserves and resources had been reported previously.
  • The FY24 production guidance of 21.5-24.5 mbbl/d with US$205-235 mm opex and US$135-155 mm capex has been re-iterated.
  • Current production continues to be high, with average production for the first half of March of ~23,000 bbl/d, including ~7.9 mbbl/d for Jasmine, 7.2 mbbl/d for Nong Yao, 2.9 bbl/d for Manora and 4.9 mbbl/d for Wassana.

Boise Cascade Corporation: These 4 Pivotal Factors Are Needle-Movers For Its Stock In 2024 & Beyond!

By Baptista Research

  • This is our first report on building and wooden products producer, Boise Cascade.
  • The company, which operates in the building materials and wood products sectors, reported full-year net income of $483.7 million or $12.12 per diluted share on sales of $6.8 billion.
  • This showcase of profitability came along with successful execution of the company’s growth strategy with a mix of organic and acquisition initiatives.

VAALCO Energy (NYSE: EGY): EG unlocked

By Auctus Advisors

  • The final documents for the Joint Operating agreement (JOA) for the Venus-Block P Plan of Development have now been signed by all the partners.
  • The JOA has also been approved by the EG government.
  • The Block P PSC is for 25 years from the date of approval.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Industrials: CIMC Vehicle Group Co Ltd, Sinotrans, Ocean Wilsons Holdings, CIMC Enric Holdings, US Treasury (10 Yr Generic), Isoteam Ltd, AZEK /, Simpson Manufacturing Co, Inc and more

By | Daily Briefs, Industrials

In today’s briefing:

  • CIMC Vehicles (1839 HK): Vote on 18 April as Uncertainty Lingers on the 90% Acceptance Threshold
  • Sinotrans (598. HK) Continues to Deliver
  • Quiddity Leaderboard F100/​​​250 Jun 24: LONG OCN – SHORT FSJ Could Be Interesting
  • CIMC Enric (3899 HK): Positive Takeaways from Post-Result Call
  • CIMC (1839 HK): 18th April Shareholder Vote
  • Downgrading Real Estate to Underweight; Bullish Outlook Intact; Broadening Participation
  • kopi-C with ISOTeam’s CEO: “Why I’m investing in both drones and professional development”
  • The AZEK Company: Initiation of Coverage – Is The Robust Demand in Residential Markets Likely To Last? – Major Drivers
  • Simpson Manufacturing Co.: Initiation Of Coverage – 4 Pivotal Factors Shaping Its Growth Trajectory! – Financial Forecasts


CIMC Vehicles (1839 HK): Vote on 18 April as Uncertainty Lingers on the 90% Acceptance Threshold

By Arun George

  • CIMC Vehicle Group Co Ltd (1839 HK) has despatched the offer document, and the H Share HK$7.50 offer is open. The H Shareholders class vote is on 18 April.  
  • The key condition is approval by at least 75% of independent H Shareholders (<10% of all independent H Shareholders rejection) along with a 90% minimum acceptance condition.  
  • The de-rating of peers and ongoing US investigation favours meeting the 90% threshold. However, the dire minority AGM/EGM participation rates suggest that retail apathy may derail the offer. 

Sinotrans (598. HK) Continues to Deliver

By Rikki Malik

  • Cost and business optimisations lead to increased profits as revenues drop due to freight rate declines
  • Successfully pivoting by geography as the global trading environment changes
  • The company increases its dividend payout in a sign of confidence for the future

Quiddity Leaderboard F100/​​​250 Jun 24: LONG OCN – SHORT FSJ Could Be Interesting

By Janaghan Jeyakumar, CFA

  • In this insight, we take a look at the potential index changes for F100 and F250 in the run-up to the June 2024 index rebal event.
  • There could be up to three intra-review changes for the F250 index during the next two months.
  • Separately, there could be one change for F100 and two changes for F250 during the regular rebalance in June 2024.

CIMC Enric (3899 HK): Positive Takeaways from Post-Result Call

By Osbert Tang, CFA

  • Despite weaker 2H23 results, CIMC Enric Holdings (3899 HK) guided for solid recovery in FY24. Order backlogs reached Rmb22.9bn, which almost equals the full-year revenue.
  • Clean energy segment will be supported by vessel demand, hydrogen orders, and Angang Steel project contribution. Chemical and environmental segment should rebound in 2H24.
  • Liquid food spin-off is in process and it has won several domestic whiskey projects. As net cash equals 13% of share price, payout will be maintained at 50% (FY22: 40%). 

CIMC (1839 HK): 18th April Shareholder Vote

By David Blennerhassett

  • On the 11th March, SOE-backed CIMC Vehicle Group Co Ltd (1839 HK) announced a firm Offer at HK$7.50/H-share from its major shareholder, CIMC Group. Terms are final. 
  • CIMC Group holds 74.24% of the H-shares and will abstain from voting at the H-share class meeting. 14.21% of the remaining 25.76% H-shares have given irrevocables supporting the Offer.
  • The Circular is now out. The shareholder vote is the 18th April. Payment is the 13th May, IF unconditional on the first close. This looks done.

Downgrading Real Estate to Underweight; Bullish Outlook Intact; Broadening Participation

By Joe Jasper

  • Our bullish outlook initiated on November 7, 2023 remains intact; this intermediate-to-long-term outlook is likely to stay in place as long as 4800 support holds on the SPX (7-10% downside).
  • To be clear, we aren’t calling for a pullback to 4800; we view it as a worst-case scenario for the S&P 500, and we want to be prepared for anything.
  • Shorter-Term, we remain bullish on the S&P 500 and Nasdaq 100 (QQQ) as they both refuse to close below their 20-day MAs for more than 2-3 consecutive days.

kopi-C with ISOTeam’s CEO: “Why I’m investing in both drones and professional development”

By Geoff Howie

  • kopi-C with ISOTeam’s CEO: “I’m investing in both drones and professional development” For people who live in Housing Development Board (HDB) flats in Singapore, drones may soon become a common sight.
  • ISOTeam, which specialises in maintaining and upgrading buildings, has been using drones for façade inspections since 2021.

The AZEK Company: Initiation of Coverage – Is The Robust Demand in Residential Markets Likely To Last? – Major Drivers

By Baptista Research

  • This is our first report on the AZEK Company, leading manufacturer of eco-friendly building products.
  • The company reported an 11% net sales increase year-over-year in Q1 2024.
  • Excluding the recently divested Vycom business, net sales increased 22% year-over-year, driven by the strong performance of its residential sector.

Simpson Manufacturing Co.: Initiation Of Coverage – 4 Pivotal Factors Shaping Its Growth Trajectory! – Financial Forecasts

By Baptista Research

  • This is our first report on building construction product manufacturer, Simpson Manufacturing Company.
  • The company showcased strong execution in 2023 amid a challenging year, outperforming the housing market via robust customer demand and expansion of production lines.
  • With annual net sales of $2.2 billion, a 21.5% operating income margin, and a record $8.26 of earnings per diluted share, the company emerged resilient.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief TMT/Internet: Globalwafers, Roland DG Corp, Micron Technology, Tencent, Delta Electronics, Bharti Hexacom, WCP, Charter Communications , Oracle Corp, Zhejiang Taimei Medical Technology Co Ltd and more

By | Daily Briefs, TMT/Internet

In today’s briefing:

  • Globalwafers GDR Offering – Coming to Market Earlier than Anticipated
  • Roland DG (6789 JP): Taiyo Hoping for the Best as Brother Plays the Waiting Game
  • Micron’s Earnings and Broadcom’s Accelerators
  • [Tencent (700 HK, BUY, TP HK$351) TP Change]: Improvement of Earning Quality Should Be Sustainable
  • Delta Taiwan Vs. Thailand Monitor: Delta Taiwan Surges As New AI Play; But Shorts Amassing as Well
  • Bharti Hexacom IPO: The Bear Case
  • W-Scope IPO Lock-Up – Part of the Parent’s Stake Will Be Freed, but It’s Been Adding Instead
  • Charter Communications Inc (CHTR) – Tuesday, Dec 26, 2023
  • Oracle Corporation: How Long Will The Cloud Revenue Growth Last? – Major Drivers
  • Pre-IPO Zhejiang Taimei Medical Technology – Be Cautious About the “valuation Bubble”


Globalwafers GDR Offering – Coming to Market Earlier than Anticipated

By Ethan Aw

  • Globalwafers (6488 TT) is looking to raise up to US$681m in its GDR offering. The proceeds will be used to purchase raw materials overseas.
  • The deal is a somewhat large one to digest at 20.2 days of three month ADV and the proceeds will be used to purchase raw materials overseas. 
  • In this note, we run the deal through our ECM framework and comment on deal dynamics.

Roland DG (6789 JP): Taiyo Hoping for the Best as Brother Plays the Waiting Game

By Arun George

  • In response to Roland DG Corp (6789 JP) request, on 22 March, Taiyo said it was considering a revised offer. However, Taiyo has since remained silent. 
  • Despite discussions with Brother Industries (6448 JP), the Board have not been able to eliminate dis-synergies concerns. The Board has left the decision to accept the Taiyo offer to shareholders.
  • While the Board is trying to dissuade Brother, Brother will take its offer directly to shareholders if the Taiyo offer fails. Taiyo’s behaviour suggests a reluctance to bump. 

Micron’s Earnings and Broadcom’s Accelerators

By Douglas O’Laughlin

  • I wrote about this in my recent post about HBM, and it seems almost everything I talked about became true. HBM is going to bail out the memory markets meaningfully.
  • Let’s talk about earnings, but I was hoping you could keep this post in mind while I discuss Micron.
  • These are the kinds of beats we start to see when the cycle turns. Now, the stocks have begun to anticipate this, but given the pricing dynamics of HBM, I feel very confident in Micron’s ability to hit a new cycle high in profitability.


[Tencent (700 HK, BUY, TP HK$351) TP Change]: Improvement of Earning Quality Should Be Sustainable

By Ying Pan

  • Tencent reported C4Q23 revenue, IFRS operating profit, and non-IFRS net income in-line with our estimates and in-line with consensus, with non-game revenues exceeding while game revenue missing expectations;
  • We believe the shift from game to non-game should enhance Tencent multiples but the market might have concerns on the sustainability of this change. 
  • We believe this change is sustainable with game revenue reaccelerating and non-game revenue continues to gain weight. We cut TP by 3% to reflect slow game recovery in C1H24.

Delta Taiwan Vs. Thailand Monitor: Delta Taiwan Surges As New AI Play; But Shorts Amassing as Well

By Vincent Fernando, CFA

  • Delta Taiwan Outperforms Delta Thailand After Showcasing Its AI Power Efficiency Solutions at NVIDIA Corp (NVDA US)’s GTC Conference 
  • Delta Taiwan vs. Thailand Valuation Mismatch Has Corrected Further; Delta Thailand Finally Worth Less Than Its Parent
  • Short Interest Spiked for Delta Taiwan; Taiwan Rally Short-Term Overdone Due to AI Concept Stock Hype?

Bharti Hexacom IPO: The Bear Case

By Arun George

  • Bharti Hexacom (6597372Z IN), a 70% owned subsidiary of Bharti Airtel (BHARTI IN), aims to raise up to US$513 million at an IPO price range of Rs542-570 per share.
  • In Bharti Hexacom IPO: The Bull Case, we highlighted the key elements of the bull case. In this note, we outline the bear case.
  • The bear case rests on low geographic diversification, slowing growth, share overhang from TCIL’s desire to exit fully, mid-tier revenue growth and EBITDA margin. 

W-Scope IPO Lock-Up – Part of the Parent’s Stake Will Be Freed, but It’s Been Adding Instead

By Sumeet Singh

  • WCP raised around US$314m via selling a mix of primary and secondary shares in its Korean IPO. The lockup on some of its parent’s stake will expire soon.
  • WCP designs, manufactures, and sells separators, which are one of the four core materials for secondary Lithium-ion batteries.
  • In this note, we will talk about the lock-up dynamics and updates since our last note.

Charter Communications Inc (CHTR) – Tuesday, Dec 26, 2023

By Value Investors Club

  • Charter Communications is contending with a narrowing competitive advantage in the cable industry due to the entrance of new rivals like fiber overbuilders and fixed wireless providers.
  • The company must make ongoing capital investments to stay competitive, despite uncertain returns on these investments.
  • Charter’s aggressive capital allocation approach, motivated by management incentives, is raising doubts about the company’s investment potential and future outlook.

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.


Oracle Corporation: How Long Will The Cloud Revenue Growth Last? – Major Drivers

By Baptista Research

  • Oracle Corporation had a strong performance in its third-quarter fiscal year 2024, with revenue in-line with expectations and EPS $0.02 above the high-end guidance.
  • However, both potential future performance and inherent risks were noted, which investors should closely observe.
  • A significant part of the discussion was centered on Oracle Cloud Infrastructure (OCI), tagged as the primary driver for the company’s overall revenue acceleration.

Pre-IPO Zhejiang Taimei Medical Technology – Be Cautious About the “valuation Bubble”

By Xinyao (Criss) Wang

  • Taimei has transformed from a classic SaaS model to an industrial Internet platform, with value-added digital services as main source of revenue.However, this may not necessarily bring better financial performance.
  • Considering declining revenue growth/gross margin, as well as constantly increasing customer acquisition cost, it’s highly uncertain whether Taimei can successfully turn losses into profits in 2025 as expected by management.
  • The significant valuation changes in Series E/E+/F Financing attracted the attention of Shanghai Stock Exchange.Taimei is actually not confident in its future performance. Its valuation could be lower than Yidu.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Health Care: Hanmi Science, Novo Nordisk A/S, Siloam International Hospitals, Sigma Healthcare, Mural Oncology , Immix Biopharma Inc, Legend Biotech Corp and more

By | Daily Briefs, Healthcare

In today’s briefing:

  • Hanmi Science: NPS Sides With Mother (Chairwoman) And Daughter
  • Novo Nordisk: Is the FDA Approval of Wegovy Worth an Extra $460 Bn?
  • Siloam International Hospitals (SILO IJ) – Growth Through Intensity & Efficiency
  • Sigma Healthcare (SIG AU): Merger Uncertainty To Limit Upside Potential
  • Mural Oncology Plc (MURA) – Tuesday, Dec 26, 2023
  • Immix Biopharma – Marching towards US clinical trials for NXC-201
  • Legend Biotech Corporation: Initiation of Coverage – Can They Flourish In The Competitive CAR-T Therapy Market? – Major Drivers


Hanmi Science: NPS Sides With Mother (Chairwoman) And Daughter

By Douglas Kim

  • After the market close on 26 March, it was reported that NPS has decided it will side with Chairwoman Young-Sook Song (mother) and her daughter Ju-Hyun Lim. 
  • As a result, Chairwoman Young-Sook Song (mother) and Ju-Hyun Lim have secured 40.86% of the shares, which is slightly higher than the ownership of her two sons (38.4%). 
  • In the near term, this battle for the control of the company could have a positive impact on Hanmi Science’s share price. 

Novo Nordisk: Is the FDA Approval of Wegovy Worth an Extra $460 Bn?

By Avien Pillay

  • FDA approval of Wegovy is overvalued at approx. $460 billion. Market exaggerated the worth without proper assessment of weight loss results and risks associated with the drug.
  • Clinical trials showed a 14.9% weight loss with diet and exercise; real-world results would be lower. Impact on BMI for obese individuals won’t be significant. Long-term use is questionable.
  • Competition in the GLP-1 market is fierce. Novo Nordisk faces challenges in India and China, increased capex spending, and risks from compounding pharmacies and potential legal issues.

Siloam International Hospitals (SILO IJ) – Growth Through Intensity & Efficiency

By Angus Mackintosh

  • Siloam International Hospitals (SILO IJ) released a strong set of numbers in FY2023, with increasing inpatient admissions and treatment intensity despite a normalising environment coming out of the pandemic.
  • The average revenue per occupied bed remained significantly above peers, whilst the company continued to focus on highly complex clinical programs across cardiology, neurology, oncology, and orthopaedic surgery. 
  • Siloam International Hospitals takes a blended approach to premium, value-seeker, and BPJS patients, optimising  efficiencies around the latter. Valuations and growth stack up favourably versus its peers.

Sigma Healthcare (SIG AU): Merger Uncertainty To Limit Upside Potential

By Tina Banerjee

  • Sigma Healthcare (SIG AU)‘s proposed merger with Chemist Warehouse Group is being reviewed by Australian Competition and Consumer Commission (ACCC), with decision expected in 2H24.
  • Although Sigma is witnessing continuing momentum in its business (YTD sales are up by 6.6% YoY) and reaffirmed EBIT margin guidance, merger uncertainty overshadows the improved financial performance.
  • We think near-term positives of the company have already been priced in, thereby limited room for upside potential. Merger uncertainty will remain an overhang on the share prices.

Mural Oncology Plc (MURA) – Tuesday, Dec 26, 2023

By Value Investors Club

  • MURA is a micro-cap, speculative, pre-revenue, and non-compounder company that spun off from Alkermes
  • Despite a rough start, it is gaining attention and has a market cap of $74 million with $16/share in cash
  • Morgan Stanley projects a trading value range estimate of $32-$63/share based on potential sales from their lead pipeline candidate; company is funded with $275 million in cash until 2025

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.


Immix Biopharma – Marching towards US clinical trials for NXC-201

By Edison Investment Research

Immix Biopharma is closer to dosing its first US patient for lead CAR-T asset NXC-201, with the appointment of the Memorial Sloan Kettering Cancer Center as the main clinical site for the company’s US multi-site NEXICART-2 trial assessing NXC-201 in relapsed/refractory (r/r) amyloid light chain amyloidosis (ALA). NXC-201 targets B-cell maturation antigen (BCMA) and is differentiated by its low neurotoxicity and short cytokine release syndrome (CRS) duration to date, supporting Immix’s long-term aspiration to launch the first outpatient CAR-T therapy. The NEXICART-2 study will aim to reproduce the initial results from the Phase Ib/IIa NEXICART-1 study, which reported an overall response rate (ORR) of 100% for the first 10 patients treated. Top-line data from the first 40 patients in the NEXICART-2 trial are expected in 2025, which, if positive, will likely be followed by a biologic license application, a significant milestone for the Immix. The pipeline remains engaged, with IMX-110 in Phase Ib/IIa studies for solid tumors and NXC-201 also targeting multiple myeloma (MM) and, potentially, other autoimmune indications (starting H124).


Legend Biotech Corporation: Initiation of Coverage – Can They Flourish In The Competitive CAR-T Therapy Market? – Major Drivers

By Baptista Research

  • This is our first report on biopharma player, Legend Biotech.
  • The company’s Q4 earnings call displayed a balance of positive and negative performance aspects for the company.
  • Starting with positive highlights, the outlook is promising for their lead therapy, CARVYKTI, which has received a positive opinion from the Committee for Medicinal Products for Human Use for expansion into earlier lines of treatment.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Financials: Shinhan Financial, S&P/ASX 200, Bitcoin, Greentown China, Binjiang Service Group, BRP Group , Bakkt and more

By | Daily Briefs, Financials

In today’s briefing:

  • Shinhan Financial Group Placement – Another Selldown, Momentum Is Strong but Deal Is Large
  • Block Deal Sale of 3.6% Stake in Shinhan Financial by BNP Paribas
  • EQD | S&P/ASX200 Pullback In Sight (This Week or the Next)
  • Crypto Crisp: Larry Fink vs. Gary Gensler
  • Greentown China – Earnings Flash – FY 2023 Results – Lucror Analytics
  • Binjiang (3316 HK) FY23 Results: 74% of the Market Cap in Cash, 8% Dividend Yield
  • BRP: Initiation of Coverage – 4 Pivotal Factors Driving Its Growth! – Financial Forecasts
  • Bakkt Holdings, Inc. – New CEO Comments on 4Q23 Earnings and the Way Forward


Shinhan Financial Group Placement – Another Selldown, Momentum Is Strong but Deal Is Large

By Sumeet Singh

  • BNP Paribas (BNP FP) is looking to raise around US$680m via selling 3.5% of its stake in Shinhan Financial (055550 KS).
  • This will be the fourth selldown for the stock since the start of the year. It will also be the largest one of the lot, so far.
  • In this note, we will talk about the deal dynamics and run the deal through our ECM framework.

Block Deal Sale of 3.6% Stake in Shinhan Financial by BNP Paribas

By Douglas Kim

  • After the market close on 26 March, it was announced that BNP Paribas plans to sell its 3.6% stake in Shinhan Financial in a block deal sale 18.7 million shares). 
  • The block deal sale is estimated to be about 900 billion won, which would represent one of the largest block deal sales in Korea in the past several years.
  • We have a Negative view on the Shinhan Financial Group block deal and we would not subscribe to it due to three major reasons. 

EQD | S&P/ASX200 Pullback In Sight (This Week or the Next)

By Nico Rosti

  • The S&P/ASX 200 Index has reached a specific resistance level that often precedes a short-term pullback, when this pattern is encountered.
  • The pullback may happen next week, but this week is also a potential candidate since the 2nd week up is usually pretty weak when this pattern is encountered.
  • Hold your LONG positions and cover them to hedge. Going SHORT is probably best at the end of the week, on Friday, if the week is closing up.

Crypto Crisp: Larry Fink vs. Gary Gensler

By Mads Eberhardt

  • We are witnessing an unexpected showdown in the crypto world.
  • On one side stands Larry Fink, co-founder and CEO of BlackRock, the world’s largest asset manager.
  • On the opposite side is Gary Gensler, the chair of the U.S. Securities and Exchange Commission (SEC).

Greentown China – Earnings Flash – FY 2023 Results – Lucror Analytics

By Leonard Law, CFA

Greentown China’s FY 2023 performance was satisfactory in our view, given the above-industry sales, stable top line and acceptable (albeit reduced) gross margin. Importantly, its access to onshore financing appears healthy and liquidity is adequate. In addition, the company remains active in land acquisitions and has a good quality land bank, mostly in high-tier cities in the Yangtze River Delta.

That said, leverage remained somewhat weak. Moreover, Greentown is more exposed to a prolonged industry downturn (vs. peers such as Longfor Group and China Vanke), due to its low recurring income and outsized exposure to the property development segment. This means that the company’s contracted sales and margins are likely to remain soft despite outperforming the industry. In the meantime, Greentown will likely focus on improving operating efficiency by maintaining a high sell-through rate and fast churn for its projects.

We revise our fundamental Credit Bias to “Negative” from “Stable”, and move our trade recommendation on the GRNCH 5.95 ’24s to “Buy” from “Hold” .


Binjiang (3316 HK) FY23 Results: 74% of the Market Cap in Cash, 8% Dividend Yield

By Sameer Taneja

  • Binjiang Service Group (3316 HK) posted a 42% YoY increase in revenue and 19% YoY in profits for FY23, aided by 170% revenue growth in VAS services (24% of revenues).
  • Margin decline remains a concern, with a GPM(%) decline of 510 bps to 24.8%, with declines across all business segments. 
  • Net cash increased to 74% of market capitalization, with the company declaring a dividend of 1.37 HKD/share ( implying an 8% trailing yield). 

BRP: Initiation of Coverage – 4 Pivotal Factors Driving Its Growth! – Financial Forecasts

By Baptista Research

  • This is our first report on powersport vehicles and marine products, BRP Inc. The company’s fiscal year 2024 third quarter results conference call highlighted mixed performances across its categories of operation.
  • Revenue reached $2.5 billion, which fell short of expectations due to softer demand in international markets and a temporary slowdown at the Texas-Mexico border.
  • Although these conditions negatively impacted deliveries of its off-road vehicles and ETVs over three weeks, normalcy has been restored.

Bakkt Holdings, Inc. – New CEO Comments on 4Q23 Earnings and the Way Forward

By Water Tower Research

  • Bakkt’s new President and CEO Andy Main led the earnings call, where net revenue of $16.7 million was better than pre-announced, while the GAAP EPS loss of $0.29 was worse than our expectation of a $0.19 loss, driven by higher restructuring and goodwill write-downs.
  • While 4Q23 was pretty much old news, Main highlighted how strong tailwinds in 1Q24 have led to significant notional crypto trading volume increases.
  • He stated that, “QTD notional traded volumes have been very strong, with March QTD up over ~260% from 4Q23 versus overall market activity up ~65%.”

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Consumer: BYD, Hana Tour Service, Anta Sports Products, Bukalapak.com PT Tbk, TSE Tokyo Price Index TOPIX, Alibaba Pictures, Meituan, Porsche Automobil Holding , Brunswick Corp and more

By | Consumer, Daily Briefs

In today’s briefing:

  • BYD (1211 HK): Strong Revenue in 2023 and to Change Strategy in 2024
  • HanaTour Management Sale: Minority Shareholder Tender Offer & Price Premium Assessment
  • Anta Sports (2020 HK):  2024 High Conviction Update – Earnings Beat In 2H23
  • Bukalapak.com (BUKA IJ) – On the Cusp of Breakeven
  • Shareholder Returns Should Be Examined on a Cash Basis, Not on a Net Profit Basis
  • BABA’s Babies: They Are All Grown Up! Ali Pictures: A Blockbuster Company
  • [Meituan (3690 HK, SELL, TP HK$70) TP Change]: Margin Reflects Persistent Competitive Pressure
  • Hana Tour Service: Major Shareholders Including IMM PE Likely to Sell Their Shares
  • Preference for Deleveraging, Model Update
  • Brunswick Corporation – Initiation Of Coverage – Does It Have A Sustainable Competitive Advantage? – Major Drivers


BYD (1211 HK): Strong Revenue in 2023 and to Change Strategy in 2024

By Ming Lu

  • Total revenue increase by 42% and automobile revenue increased by 49% in 2023.
  • The gross margin improved significantly in 2023, especially in 4Q23.
  • We believe BYD will move its focus from ‘low price for sales volume’ to ‘development of new vehicle models’.

HanaTour Management Sale: Minority Shareholder Tender Offer & Price Premium Assessment

By Sanghyun Park

  • HanaTour seeks new ownership after 4 years under IMM PE. Despite COVID-19 setbacks, successful restructuring attracts attention from online travel and investment giants.
  • Market rumors hint at Yanolja and Hotels.com interest, possibly intensifying acquisition competition, leading to a higher price premium. IMM’s 16.68% stake may value at ₩250B, a 35% premium.
  • Last year’s mandatory tender offer for 50%+1 share awaits legislation. Unlikely to affect HanaTour sale. Nonetheless, potential acquirers may buy additional shares, suggesting further premium formation in share price.

Anta Sports (2020 HK):  2024 High Conviction Update – Earnings Beat In 2H23

By Steve Zhou, CFA

  • At noon time today, Anta Sports Products (2020 HK) released strong 2023 results which beat expectations. 
  • Anta currently trades at a forward PE of 18x based on estimated 2024 earnings (assuming a conservative 15% yoy growth in 2024 earnings). 
  • I expect the company’s net profit to grow 15-20% CAGR in 2024-2026.  Anta’s historical forward PE is around 24x since 2017. 

Bukalapak.com (BUKA IJ) – On the Cusp of Breakeven

By Angus Mackintosh

  • Bukalapak.com (BUKA IJ) booked a slightly weaker finish to the year than expected with a slowdown in revenue growth in 4Q2023 and a miss on adjusted EBITDA breakeven.
  • The key reason was a thinning out of non-performing specialty businesses which impacted short-term revenues but will improve revenues and adjusted EBITDA. as the focus shifts to higher take-rate businesses.
  • Bukalapak.com PT Tbk (BUKA IJ) is guiding for +15-20% revenue growth and positive adjusted EBITDA in 2024 with execution on this being paramount. Valuations remain attractive.

Shareholder Returns Should Be Examined on a Cash Basis, Not on a Net Profit Basis

By Aki Matsumoto

  • The pace of share repurchases in 2023 (+1.4%, YoY) is not sufficient compared to the increase in corporate profits, and there is much room for reconsideration of cash allocations.
  • In Japan, where many manufacturers keep CapEx within the depreciation, it’s more important to verify whether shareholder return is appropriate on a cash basis rather than a net income basis.
  • Companies that fail to formulate measures to generate ROE that exceeds the cost of capital in accordance with TSE requests are not able to achieve an appropriate cash allocation.

BABA’s Babies: They Are All Grown Up! Ali Pictures: A Blockbuster Company

By David Mudd

  • Alibaba Pictures (1060 HK) is expanding rapidly into complimentary areas such as online ticketing of cinema and live events with the recent acquisition of  Damai.cn from parent Alibaba.
  • Alibaba Group Holding (9988 HK) is considering injecting other media platform assets like Youku  to realize synergies among its portfolio of companies.
  • Ali Pictures (Alipics) legacy film production business continues to expand globally with its American film production company, Amblin which is a partnership with Steven Spielberg.

[Meituan (3690 HK, SELL, TP HK$70) TP Change]: Margin Reflects Persistent Competitive Pressure

By Ying Pan

  • Meituan reported C4Q23 revenue beat our estimate/consensus by 0.7%/1.4%; operating profit beat our estimate/consensus by 37.3%/48.6%, mainly due to order volume surprise, which is unsustainable in our view.
  • However, we think Meituan’s near term pressures did not change: (1) core biz OPM drop due to rising low-price orders and subsidies; (2) resuming competition from Eleme/Douyin/PDD
  • We maintain the stock as SELL rating but raise TP by HK$13 to HK$70 to factor in the loss cutting commitment in the community group buying biz.

Hana Tour Service: Major Shareholders Including IMM PE Likely to Sell Their Shares

By Douglas Kim

  • Hana Tour Service (039130 KS), the number one travel platform in Korea,  announced that IMM PE (controlling shareholder of the company) is planning to sell its controlling stake. 
  • The total stake in the company that is up for sale could rise to 27.78%, including stakes held by Hana Tour founder Park Sang-hwan and co-founder Kwon Hee-seok. 
  • Potential buyers of the controlling stake in Hana Tour include Yanolja, Hotels.com, Booking.com, and Trip.com.

Preference for Deleveraging, Model Update

By Jesus Rodriguez Aguilar

  • Net debt improved by around €1 billion to c. €5.8 billion. Prioritising deleveraging and allocations to new venture investments over dividends seem to have a negative impact on valuation.
  • Porsche SE is viewed as a holding company of Volkswagen Group, which should warrant a discount of 15%-25% on the stock, instead of the massive 44.6% discount to NAV.
  • Assuming a typical company holding discount of 15-25% range, the current share price indicates Porsche SE is liable for the whole c. €6.5 billion legal claims.

Brunswick Corporation – Initiation Of Coverage – Does It Have A Sustainable Competitive Advantage? – Major Drivers

By Baptista Research

  • This is our first report on recreation products manufacturer, Brunswick Corporation.
  • Despite market headwinds, the company reports another successful year, claiming to have accomplished the second highest sales and adjusted earnings per share in its existence.
  • In particular, Brunswick stresses the progress of its strategic initiatives, continued market share increases, cost control, the launch of new products, and an enhancement in operational efficiency.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Thailand: Valeura Energy Inc and more

By | Daily Briefs, Thailand

In today’s briefing:

  • Valeura Energy (TSX: VLE): Additional exploration upside. Lower decommissioning liabilities


Valeura Energy (TSX: VLE): Additional exploration upside. Lower decommissioning liabilities

By Auctus Advisors

  • FY23 production, YE23 net cash and YE23 reserves and resources had been reported previously.
  • The FY24 production guidance of 21.5-24.5 mbbl/d with US$205-235 mm opex and US$135-155 mm capex has been re-iterated.
  • Current production continues to be high, with average production for the first half of March of ~23,000 bbl/d, including ~7.9 mbbl/d for Jasmine, 7.2 mbbl/d for Nong Yao, 2.9 bbl/d for Manora and 4.9 mbbl/d for Wassana.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Australia: S&P/ASX 200, Sigma Healthcare and more

By | Australia, Daily Briefs

In today’s briefing:

  • EQD | S&P/ASX200 Pullback In Sight (This Week or the Next)
  • Sigma Healthcare (SIG AU): Merger Uncertainty To Limit Upside Potential


EQD | S&P/ASX200 Pullback In Sight (This Week or the Next)

By Nico Rosti

  • The S&P/ASX 200 Index has reached a specific resistance level that often precedes a short-term pullback, when this pattern is encountered.
  • The pullback may happen next week, but this week is also a potential candidate since the 2nd week up is usually pretty weak when this pattern is encountered.
  • Hold your LONG positions and cover them to hedge. Going SHORT is probably best at the end of the week, on Friday, if the week is closing up.

Sigma Healthcare (SIG AU): Merger Uncertainty To Limit Upside Potential

By Tina Banerjee

  • Sigma Healthcare (SIG AU)‘s proposed merger with Chemist Warehouse Group is being reviewed by Australian Competition and Consumer Commission (ACCC), with decision expected in 2H24.
  • Although Sigma is witnessing continuing momentum in its business (YTD sales are up by 6.6% YoY) and reaffirmed EBIT margin guidance, merger uncertainty overshadows the improved financial performance.
  • We think near-term positives of the company have already been priced in, thereby limited room for upside potential. Merger uncertainty will remain an overhang on the share prices.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars